International Healthway Corporation (IHC) is a Singapore-listed firm that runs hospitals, nursing homes, and step-down care across Asia, including Japan, China, and Malaysia. It just bought Healthway Medical Corporation, which shows that it is making a big strategic change toward a bigger primary care network.
What Is International Healthway Corporation?
International Healthway Corporation (SGX: IHC) is a Singapore-based company that offers a full range of healthcare and medical services. When the company started, it had two goals: to deliver patient-centered medical treatment to people throughout all of Asia and to build a wide range of healthcare real estate assets.
IHC is different from single-specialty healthcare firms since it works in a wide range of areas, from nursing homes for the elderly in Japan to full-service hospitals in China, and from step-down care facilities to primary care clinics. This integrated methodology means that it cares for patients from the time they are sick until they are well again. It is one of the few companies in Southeast Asia with a real continuum-of-care business model.
The Singapore Exchange (SGX-ST) has a Catalist board where the company is listed. This makes it easy for both retail and institutional investors to get into the Asian healthcare sector.
History and Background
International Healthway Corporation was founded in Singapore and created its first portfolio by buying healthcare assets in the Asia-Pacific area that were strategically chosen.
Key milestones in IHC’s corporate history:
| Year | Milestone |
| Early 2010s | Founded and listed on SGX Catalist as an integrated healthcare provider |
| 2015 | Published Annual Report highlighting assets in Japan, China (Wuxi & Chengdu), and Malaysia |
| 2016–2017 | Faced shareholder activism; Quarz Capital publicly pushed for governance reforms and debt reduction |
| 2017 | New directors appointed at Extraordinary General Meeting to lead operational turnaround |
| 2025 | Announced acquisition of Healthway Medical Corporation; stock surged up to 21% on announcement |
| 2026 | Continued trading in penny stock range with active restructuring efforts underway |
The company’s rise is linked to a larger demographic shift in Asia. For example, Japan’s population is getting older, China’s cities are growing quickly, and Southeast Asia’s middle class is getting bigger, all of which are increasing demand for high-quality healthcare services.
Core Business Segments
IHC operates through several distinct but interconnected business pillars:
1. Elderly and Nursing Care
IHC’s nursing home portfolio in Japan is one of its most stable and profitable areas. Japan’s population is getting older quickly, with more than 29% of people over 65 (Cabinet Office, Japan, 2023). This makes elder care facilities a constantly high-demand asset type.
2. Hospital Operations and Medical Facilities
The company owns and runs hospitals in China. It has assets in Wuxi, where it runs a hospital, and Chengdu, where it has property for a hospital. These assets in China are aimed at the country’s quickly growing private healthcare market.
3. Primary and Preventive Care
Through its acquisition of Healthway Medical Corporation, IHC is scaling into primary care — including family medicine, dental services, specialist referrals, and health screening across Singapore and China.
4. Step-Down and Transitional Care
Step-down care facilities are an important aspect of IHC’s continuum-of-care strategy because they fill the gap between short hospital stays and full recovery at home. These units lower the number of patients who have to go back to the hospital and the expense per patient.
5. Women, Children, and Maternity Services
IHC runs maternity homes and health services just for women and children. These services fill the gaps in prenatal, perinatal, and pediatric care in numerous Asian markets.
Geographic Footprint Across Asia
| Country | Type of Asset | Status |
| Japan | Nursing homes (elderly care) | Operational |
| China (Wuxi) | Hospital | Operational |
| China (Chengdu) | Hospital landbank | Development stage |
| Malaysia (Kuala Lumpur) | Land bank | Non-core / potential divestment |
| Singapore | Primary care clinics (via Healthway Medical) | Operational |
IHC’s global spread is a smart move: Japan offers stability because of its demographics, China offers growth through market expansion, and Singapore is one of Asia’s most respected healthcare jurisdictions, which gives IHC a regulatory foundation.
Recent Developments (2025–2026)
Acquisition of Healthway Medical Corporation
The most significant recent development for IHC is the acquisition of Healthway Medical Corporation, a well-established provider operating a network of medical centres and clinics in Singapore and China. Healthway Medical’s service portfolio includes:
- Primary healthcare and family medicine
- Dental services
- Health screening and diagnostics
- Specialty services (orthopedics, cardiology, ophthalmology, gastroenterology, and more)
- Medical aesthetics and wellness facilities
- Healthcare benefits management for corporations and insurers
This acquisition gives IHC a significant downstream presence in everyday primary care — a strategic shift from its historically asset-heavy hospital and nursing home model.
Stock Activity
In 2026, IHC shares continued to trade at single-digit cent levels on the SGX Catalist. However, the stock demonstrated strong sensitivity to corporate action news — surging approximately 21% upon acquisition announcements in 2025. This pattern is characteristic of healthcare penny stocks in Asia, where sentiment can shift rapidly on material disclosures.
IHC vs. Competitors: Comparison Table
| Feature | International Healthway Corp (IHC) | Raffles Medical Group | IHH Healthcare |
| Listing | SGX Catalist | SGX Mainboard | Bursa Malaysia / SGX |
| Primary Market | Asia (Japan, China, Singapore) | Singapore, regional | Pan-Asia (11 countries) |
| Core Offering | Integrated healthcare + real estate | Private hospitals + clinics | Hospitals, clinics, labs |
| Elderly Care | Yes (Japan nursing homes) | Limited | Limited |
| Primary Care (post-acquisition) | Yes (via Healthway Medical) | Yes | Yes |
| Market Capitalization | Small-cap / penny stock | Mid-cap | Large-cap |
| Risk Profile | Higher (governance + debt history) | Lower | Low-medium |
Services Offered by IHC-Affiliated Facilities
Through its own assets and the Healthway Medical network, IHC now provides access to a broad range of healthcare services:
Primary and General Care
- Family medicine consultations
- Preventive health screenings
- Vaccination programmes
- Chronic disease management (diabetes, hypertension, asthma)
Specialist Services
- Orthopaedics and sports medicine
- Cardiology
- Gastroenterology and hepatology
- Ophthalmology
- Psychiatry and psychology
- Colorectal surgery
- Women’s health and obstetrics/gynaecology
- Child development and paediatrics
Dental Services
- General dentistry
- Specialist dentistry and dental surgery
Medical Aesthetics and Wellness
- Aesthetic medicine
- Wellness assessments
Elderly and Long-Term Care (Japan)
- Residential nursing care
- Rehabilitation services
- Dementia care programmes
Financial Overview and Stock Performance
IHC’s financial history reflects a company in transition. Key characteristics of its financial profile include:
- Heavy debt on the balance sheet: aggressive growth in the past few years has resulted in high debt levels that have hurt shareholder sentiment.
- Classification as a penny stock: The stock has always traded at low prices, with big short-term jumps linked to company news.
- NAV discount: At its lowest point, IHC traded at a reported 48% discount to Net Asset Value (NAV), which means that investors lost faith in management.
- Signs of recovery: Recent acquisitions and changes in leadership have sparked renewed interest from institutions.
Why International Healthway Matters for Healthcare in Asia
IHC’s narrative is a reflection of bigger trends that are changing how healthcare is delivered across Asia:
1. A growing number of older people, Japan’s older population: China’s quickly aging workforce, and Singapore’s aging baby boomer group are all creating a structural need for the same services that IHC offers, such as nursing homes, specialized care, and rehabilitation centers.
2. The Growth of Integrated Healthcare Models: More and more, global health systems choose integrated care, which means that one clinician takes care of a patient in all three types of care: primary, specialized, and long-term. This concept is similar to IHC’s portfolio.
3. Private Healthcare Expansion in China: China’s government has actively encouraged private hospital development. IHC’s hospital assets in Wuxi and Chengdu position it at the frontier of this expanding market.
4. Post-Pandemic Health Awareness: Across Asia, consumer health awareness has surged post-COVID-19. Demand for preventive health screenings, wellness checks, and primary care has grown substantially — aligning with Healthway Medical’s primary care model.
Frequently Asked Questions
What does the International Healthway Corporation do? IHC is a Singapore-listed integrated healthcare corporation that runs hospitals, nursing homes, primary care clinics, and other medical facilities in Japan, China, and Singapore. It also has property in Malaysia that is used for healthcare.
Where is International Healthway Corporation listed? The Singapore Exchange (SGX-ST) has IHC listed on its Catalist board with the ticker symbol IHC.
What is the Healthway Medical Corporation acquisition? IHC said in 2025 that it has bought Healthway Medical Corporation, a network of primary care and specialized clinics that serve Singapore and China. This contract greatly expands IHC’s ability to provide healthcare downstream.
Is IHC a good investment? IHC is a high-risk investment because of its past problems with governance, large debt levels, and status as a penny stock. It has the potential to go up because of expansion in Asian healthcare, but investors should do their homework and talk to a skilled financial advisor.
What countries does IHC operate in? IHC has healthcare operations and/or assets in Japan, China (Wuxi, Chengdu), Singapore, and Malaysia.
What makes IHC different from other Asian healthcare companies? IHC stands out because it combines real estate development with healthcare service delivery and uses a continuum-of-care model that includes nursing homes for the elderly, hospitals, and primary care.
Research and References
The information in this article draws from the following sources:
- International Healthway Corporation Annual Report 2015 — Singapore Exchange (SGX) corporate filings. Available at: links.sgx.com
- CBInsights Company Profile: International Healthway Corp — Business intelligence and financial data overview. cbinsights.com
- Quarz Capital Investment Thesis on IHC (2017) — Shareholder activist analysis including NAV discount and governance recommendations. quarzcapital.com
- GlobalData: Healthway Medical Corp Ltd Company Profile — Service portfolio and operations overview. globaldata.com
- CBonds: International Healthway Corp LTD Issuer Profile — Financial classifications and bond data. cbonds.com
- Cabinet Office of Japan (2023) — Annual Report on the Ageing Society. cao.go.jp
- Singapore Exchange (SGX) Catalist Listing Rules — Corporate governance requirements for Catalist-listed companies. sgx.com
- World Health Organization: Ageing and Health Fact Sheet (2022) — Global demographic data on aging populations. who.int
Nicola Donelan, PhD, brings more than 20 years of deep scientific expertise and over a decade of dedicated medical writing to every project she touches. Her work sits at the intersection of rigorous research and clear, purposeful communication — turning complex bioscience, pharmaceutical, and healthcare knowledge into content that informs, persuades, and performs